A new study looked at the effect of semaglutide vs. tirzepatide on weight loss over a 72 week period. At the end of the 72 ...

People who took Zepbound had greater reductions in waist circumference and body weight, a study found.Fact checked by Nick ...

A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions in body weight and waist circumference.

Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.

If you’re struggling with weight, you’re not alone. Around 42 percent of American adults have obesity. In addition to ...

The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...

American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in its use for young people with obesity, new data shared with Reuters shows.

The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...

Poison control experts say calls related to GLP-1 weight-loss drugs like Wegovy and Zepbound are rising, with symptoms like ...